Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00653952
Recruitment Status : Terminated (Poor accrual)
First Posted : April 7, 2008
Last Update Posted : April 27, 2010
Sponsor:
Collaborators:
Sequus Pharmaceuticals
ALZA
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Actual Study Completion Date : April 2000